Semaglutide/GLP-1: Your Latest FDA-Approved Option for Sustainable Weight Loss

Semaglutide: A Potential Game-Changer Obesity is a condition that currently affects over 40% of adults in the United States. Another 30% are considered overweight. This puts these adults at risk for heart disease, stroke, and diabetes and is linked to an increased risk of certain types of cancer. Losing just 5% to 10% of body…

Semaglutide: A Potential Game-Changer

Obesity is a condition that currently affects over 40% of adults in the United States. Another 30% are considered overweight. This puts these adults at risk for heart disease, stroke, and diabetes and is linked to an increased risk of certain types of cancer. Losing just 5% to 10% of body weight has been associated with a reduced risk of cardiovascular disease in adult patients who are overweight or obese. It has also been shown to lower the risk of getting diabetes by 58%. While there is no “magic pill” that will cure obesity immediately, researchers have created a variety of medications to address various aspects of an individual’s struggle with weight. When diet and exercise alone do not offer the expected and desired results, obesity must be viewed differently. Instead of being a willpower problem, it is a chronic metabolic disease. With this renewed understanding of obesity, practitioners and patients can work together to find a solution that works for their bodies and lifestyles. 

The ultimate goal? Health, of course. Losing weight can improve self-perception and mood, but the emphasis should always be on health and not achieving a certain size- although that certainly is a desired by-product. The goal of anti-obesity medications is to reset the “set point,” a term that describes a weight range the body tries to maintain. It’s important to understand this weight range varies from person to person. By resetting this “set point,” patients have a better chance of losing weight and maintaining that weight loss. Anti-obesity medications can also help with other weight-related medical problems such as high blood pressure, cholesterol levels, blood sugar levels, and delaying the onset of type 2 diabetes. The GLP-1 medications, in particular, have also been found to decrease…

Read full article Source